MRC Biostatistics UnitThe AGILE clinical trial platform has been launched specifically to test new COVID-19 treatments, faster than ever before. It bridges the gap between non-human trials and large-scale testing, so potential new treatments can go through the important testing stages in a matter of months rather than years, while maintaining a high level of safety at […]
New MPhil in Population Health Sciences
A brand new MPhil in Population Health Sciences (PHS) has been launched by the University of Cambridge. It is jointly run by the Department of Public Health and Primary Care, the MRC Epidemiology Unit and the MRC Biostatistics Unit (BSU), with contributions from colleagues across the University. The MPhil PHS is a postgraduate master’s course, […]
Are we underestimating the spread of COVID-19 based on seroprevalence surveys?
Researchers from the MRC Biostatistics Unit, University Hospital Wales in Cardiff, and St George’s, University of London and St George’s Hospital published an editorial piece in the British Medical Journal today titled ‘Are we underestimating seroprevalence of SARS-CoV-2?’. In this article, the researchers provide reasons why surveys of how far the novel coronavirus (SARS-CoV-2) has […]
Tackling COVID-19: Professor Daniela De Angelis
Since January this year, Daniela De Angelis and her team have been informing the UK Government’s response to the COVID-19 pandemic. Their real-time model of transmission of the virus is helping to track and predict its course as information accumulates over time. I work for the Medical Research Council (MRC) Biostatistics Unit (BSU), a department […]
- 1
- 2
- 3
- …
- 44
- Next Page »